• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

I 期非小细胞肺癌手术治疗与放疗的结果比较:SEER 数据库分析。

Outcomes following surgical treatment compared to radiation for stage I NSCLC: a SEER database analysis.

机构信息

Department of Epidemiology, University of Nebraska Medical Center, Omaha, NE, United States.

出版信息

Lung Cancer. 2013 Oct;82(1):90-4. doi: 10.1016/j.lungcan.2013.06.021. Epub 2013 Jul 31.

DOI:10.1016/j.lungcan.2013.06.021
PMID:23910907
Abstract

INTRODUCTION

Outcomes following surgery are better than following radiation therapy (RT), for stage I NSCLC. Whether this is due to selection of healthier patients for surgery is unclear. This study was undertaken to compare outcomes between surgical patients and patients who were surgical candidates but did not receive surgery.

METHODS

Data of patients with stage I NSCLC between 1988 and 2007, included in the SEER database were analyzed. Overall survival (OS) was examined by treatment type (surgery only, radiation only, surgery and radiation, and no treatment). OS was compared between RT patients who refused surgery and those not fit for surgery. Cox proportional hazards model was used to compare outcomes by treatment type.

RESULTS

Data from 8579 patients with stage I NSCLC during 1988-2007 were analyzed. Use of RT alone increased during the study period. An increasing proportion of patients with stage I lung cancer chose to have no treatment. On multivariate analysis, OS was better among patients who had surgery. There was a 56% improvement in survival among patients who had surgery compared to fit patients who refused surgery (HR 0.437, 95% CI 0.301-0.632). Patients who refused surgery had a better OS than those who were not fit for surgery (log-rank p = 0.01). Patients who received RT alone or no treatment had a significant improvement in five-year OS during the latter part of the study period (1998-2002 vs. 1988-1992).

CONCLUSIONS

In medically fit patients, outcomes following surgery are better than those following conventional radiation. Hence surgery should be chosen over conventional radiation, whenever possible. Outcomes following RT show an improvement over time reflecting improvement in radiation techniques.

摘要

简介

对于 I 期非小细胞肺癌,手术治疗的效果优于放射治疗(RT)。这是否是由于手术选择了更健康的患者尚不清楚。本研究旨在比较手术患者与手术候选但未接受手术的患者的结局。

方法

分析了 1988 年至 2007 年间 SEER 数据库中 I 期非小细胞肺癌患者的数据。根据治疗类型(仅手术、仅放疗、手术和放疗、无治疗)检查总生存率(OS)。比较了拒绝手术和不适合手术的 RT 患者的 OS。使用 Cox 比例风险模型比较治疗类型的结果。

结果

分析了 1988-2007 年期间 8579 例 I 期非小细胞肺癌患者的数据。单独使用 RT 的比例在研究期间有所增加。越来越多的 I 期肺癌患者选择不治疗。多变量分析显示,手术患者的 OS 更好。与适合手术但拒绝手术的患者相比,手术患者的生存改善了 56%(HR 0.437,95%CI 0.301-0.632)。拒绝手术的患者比不适合手术的患者的 OS 更好(对数秩检验,p = 0.01)。单独接受 RT 或未接受治疗的患者在研究后期(1998-2002 年与 1988-1992 年)的五年 OS 显著提高。

结论

在适合手术的患者中,手术后的结果优于常规放疗。因此,只要有可能,就应选择手术而不是常规放疗。随着时间的推移,RT 的结果显示出改善,反映了放射技术的改进。

相似文献

1
Outcomes following surgical treatment compared to radiation for stage I NSCLC: a SEER database analysis.I 期非小细胞肺癌手术治疗与放疗的结果比较:SEER 数据库分析。
Lung Cancer. 2013 Oct;82(1):90-4. doi: 10.1016/j.lungcan.2013.06.021. Epub 2013 Jul 31.
2
Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer.热消融术在老年早期非小细胞肺癌患者中与亚肺叶切除术结果相当。
J Vasc Interv Radiol. 2014 Jan;25(1):1-9.e1. doi: 10.1016/j.jvir.2013.10.018.
3
Impact of preoperative radiation on survival of patients with T3N0 >7-cm non-small cell lung cancers treated with anatomic resection using the Surveillance, Epidemiology, and End Results database.术前放疗对应用监测、流行病学和最终结果数据库行解剖性切除术的 T3N0 >7cm 非小细胞肺癌患者生存的影响。
J Surg Res. 2013 Sep;184(1):10-8. doi: 10.1016/j.jss.2013.03.053. Epub 2013 Apr 3.
4
An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.术前贫血与接受单纯手术治疗的早期非小细胞肺癌患者生存率降低之间的关联。
Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1438-43. doi: 10.1016/j.ijrobp.2004.12.038.
5
Impact of neoadjuvant radiation on survival in stage III non-small-cell lung cancer.新辅助放疗对 III 期非小细胞肺癌患者生存的影响。
Int J Radiat Oncol Biol Phys. 2011 Apr 1;79(5):1388-94. doi: 10.1016/j.ijrobp.2009.12.066. Epub 2010 Jun 3.
6
A population-based comparative effectiveness study of radiation therapy techniques in stage III non-small cell lung cancer.一项基于人群的 III 期非小细胞肺癌放疗技术的对照疗效研究。
Int J Radiat Oncol Biol Phys. 2014 Mar 15;88(4):872-84. doi: 10.1016/j.ijrobp.2013.12.010. Epub 2014 Feb 1.
7
Impact of Radiation Therapy in Surgically Resected Limited-Stage Small Cell Lung Carcinoma.放射治疗对手术切除的局限期小细胞肺癌的影响。
Lung. 2017 Jun;195(3):341-346. doi: 10.1007/s00408-017-9992-6. Epub 2017 Mar 28.
8
Oncologic benefit of tonsillectomy in stage I and II tonsil cancer: a surveillance epidemiology and end results database review.扁桃体癌 I 期和 II 期行扁桃体切除术的肿瘤学获益:监测流行病学和最终结果数据库回顾。
JAMA Otolaryngol Head Neck Surg. 2013 Apr;139(4):362-6. doi: 10.1001/jamaoto.2013.107.
9
Radiation therapy for the treatment of unresected stage I-II non-small cell lung cancer.放射治疗用于治疗未切除的I-II期非小细胞肺癌。
Chest. 2005 Sep;128(3):1461-7. doi: 10.1378/chest.128.3.1461.
10
Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.临床ⅠA 期非小细胞肺癌亚肺叶切除术后局部区域复发的危险因素分析。
J Thorac Cardiovasc Surg. 2013 Aug;146(2):372-8. doi: 10.1016/j.jtcvs.2013.02.057.

引用本文的文献

1
Prognosis analysis of lobectomy and sublobar resection in patients ≥75 years old with pathological stage I invasive lung adenocarcinoma of ≤3 cm: a propensity score matching-based analysis.≥75岁、病理分期为I期且肿瘤直径≤3 cm的浸润性肺腺癌患者行肺叶切除术和肺段切除术的预后分析:一项基于倾向评分匹配的分析
Transl Cancer Res. 2019 Apr;8(2):574-582. doi: 10.21037/tcr.2019.03.18.
2
Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.列线图预测Ⅰ期老年小细胞肺癌患者生存的建立与验证。
Bosn J Basic Med Sci. 2021 Oct 1;21(5):632-641. doi: 10.17305/bjbms.2020.5420.
3
Time trend of mediastinal lymph node dissection in stage IA non-small cell lung cancer patient who undergo lobectomy: a retrospective study of surveillance, epidemiology, and end results (SEER) database.
接受肺叶切除术的IA期非小细胞肺癌患者纵隔淋巴结清扫术的时间趋势:一项基于监测、流行病学和最终结果(SEER)数据库的回顾性研究
J Cardiothorac Surg. 2020 Aug 1;15(1):207. doi: 10.1186/s13019-020-01215-x.
4
Does FDG PET/CT have a role in determining adjuvant chemotherapy in surgical margin-negative stage IA non-small cell lung cancer patients?在手术切缘阴性、ⅠA 期非小细胞肺癌患者中,FDG PET/CT 在确定辅助化疗中的作用如何?
J Cancer Res Clin Oncol. 2019 Apr;145(4):1021-1026. doi: 10.1007/s00432-019-02858-7. Epub 2019 Feb 13.
5
Prognostic Analysis of Limited Resection Versus Lobectomy in Stage IA Small Cell Lung Cancer Patients Based on the Surveillance, Epidemiology, and End Results Registry Database.基于监测、流行病学和最终结果登记数据库对ⅠA期小细胞肺癌患者行有限切除与肺叶切除术的预后分析
Front Genet. 2018 Nov 22;9:568. doi: 10.3389/fgene.2018.00568. eCollection 2018.
6
Sublobar resection versus lobectomy in patients aged ≤35 years with stage IA non-small cell lung cancer: a SEER database analysis.≤35岁的IA期非小细胞肺癌患者行肺叶下切除与肺叶切除的比较:一项监测、流行病学和最终结果(SEER)数据库分析
J Cancer Res Clin Oncol. 2017 Nov;143(11):2375-2382. doi: 10.1007/s00432-017-2499-y. Epub 2017 Aug 17.
7
Detection of microRNA-200b may predict the inhibitory effect of gefitinib on non-small cell lung cancer and its potential mechanism.检测微小RNA-200b可预测吉非替尼对非小细胞肺癌的抑制作用及其潜在机制。
Oncol Lett. 2016 Dec;12(6):5349-5355. doi: 10.3892/ol.2016.5365. Epub 2016 Nov 8.
8
SBRT versus lobectomy in stage I NSCLC: knowns, unknowns and its interpretation.I期非小细胞肺癌中立体定向体部放疗与肺叶切除术的比较:已知、未知及其解读
J Thorac Dis. 2016 Sep;8(9):2305-2309. doi: 10.21037/jtd.2016.08.59.